<DOC>
	<DOC>NCT00246961</DOC>
	<brief_summary>The purpose of this study is to analyse the effect on quality of life after 3 months of treatment after changing adjuvant therapy from tamoxifen to Arimidex.</brief_summary>
	<brief_title>Arimidex Observational: Reason for and Effect of Change From Tamoxifen</brief_title>
	<detailed_description />
	<mesh_term>Anastrozole</mesh_term>
	<mesh_term>Tamoxifen</mesh_term>
	<criteria>Postmenopausal Hormone sensitive breast cancer Patient uses tamoxifen or has stopped taking tamoxifen less than 7 days ago Visceral metastases Patients with signs of progression at the moment of changing therapy Patients who have used other endocrine treatments for breast cancer besides tamoxifen</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2007</verification_date>
	<keyword>Adjuvant</keyword>
</DOC>